Fresenius Medical Care (FMC) St. Aktie
38,43
EUR
-0,44
EUR
-1,13
%
Kursziele der Fresenius Medical Care (FMC) St.-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Fresenius Medical Care (FMC) St.-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 37,40 EUR | -2,98% | 13.03.2026 | |
| DZ BANK | - | - | 13.03.2026 | |
| Barclays Capital | 46,50 EUR | +20,62% | 12.03.2026 | |
| UBS AG | 37,00 EUR | -4,02% | 10.03.2026 | |
| Deutsche Bank AG | 42,00 EUR | +8,95% | 02.03.2026 | |
| Jefferies & Company Inc. | 32,00 EUR | -16,99% | 02.03.2026 | |
| Goldman Sachs Group Inc. | 40,00 EUR | +3,76% | 24.02.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 60,00 EUR | +55,64% | 03.12.2025 | |
| Bernstein Research | 54,50 EUR | +41,37% | 20.10.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Baxter International Inc. | 0 | 0 | 0 | - | - |
| BB MEDTECH AG | 0 | 0 | 0 | - | - |
| Becton, Dickinson & Co. (BD) | 0 | 0 | 0 | - | - |
| Boston Scientific Corp. | 0 | 0 | 0 | - | - |
| Carl Zeiss Meditec AG | 1 | 8 | 1 | 33,54 EUR | +38,60% |
| DaVita Inc Registered Shs | 0 | 0 | 0 | - | - |
| Drägerwerk AG & Co. KGaA Vz. | 1 | 2 | 0 | 79,00 EUR | -12,51% |
| Fresenius Medical Care (FMC) St. | 2 | 4 | 3 | 43,68 EUR | +13,31% |
| Fresenius SE & Co. KGaA (St.) | 7 | 2 | 0 | 54,32 EUR | +24,22% |
| General Electric Co. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Medtronic PLC | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 116,88 CHF | -1,90% |
| Philips N.V. | 4 | 5 | 0 | 27,25 EUR | +16,30% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Siemens AG | 6 | 2 | 2 | 260,67 EUR | +27,22% |
| Smith & Nephew plc | 0 | 0 | 0 | - | - |
| St. Jude Medical Inc. | 0 | 0 | 0 | - | - |
| STRATEC SE | 1 | 2 | 0 | 30,00 EUR | +73,01% |
| Synthes Inc. | 0 | 0 | 0 | - | - |
| Zimmer Biomet | 0 | 0 | 0 | - | - |